Summary
Antirheumatic drug concentrations have been measured in human synovial fluid and synovial tissue, and provide insights on: (1) extravascular pharmacokinetics; (2) articular pathophysiology; and (3) the factors which modify drug levels in inflamed tissues. Concentrations of free drug in synovial fluid and plasma are the same in all conditions except rheumatoid and infectious arthritis, where the most severely afflicted joints may contain lower synovial fluid drug concentrations. This finding may be relevant to the chronicity and intractability of chronic arthritis. After single-dose therapy and a characteristic ‘equilibration time’, higher concentrations are found in synovial fluid than in plasma — a phenomenon which results from relative drug sequestration across the trans-synovial diffusion barrier away from the organs of elimination. Studies of oral, parenteral, topical and intra-articular antirheumatic drug therapy are reviewed, and recommendations are made for the conduct of future studies.
Similar content being viewed by others
References
Acred, P.; Brown, D.; Clark, B. and Mizen, L.: The distribution of antibacterial agents between plasma and lymph in the dog. British Journal of Pharmacology 39: 439–446 (1970).
Aylward, M. and Maddock, J.: Total and free plasma tryptophan concentrations in rheumatoid disease. Journal of Pharmacy and Pharmacology 25: 570–572 (1973).
Aylward, M.; Maddock, J.; Rees, P.; Thomas, G.M.; Wheeldon, R. and Holly, F.: Simultaneous pharmacokinetics of beno-rylate in plasma and synovial fluid of patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 13(Suppl): 9–12 (1976).
Ballantyne, F.C.; Fleck, A. and Dick, W.C.: Albumin metabolism in rheumatoid arthritis. Annals of the Rheumatic Diseases 30: 265–270 (1971).
Barza, M.; Samuelson, T. and Weinstein, L.: Penetration of antibiotics into fibrin loci in vitro. II. Comparison of nine antibiotics: Effect of dose and degree of protein binding. Journal of Infectious Diseases 129: 66–72 (1974).
Bauer, W.; Short, C.L. and Bennett, G.A.: The manner of removal of proteins from normal joints. Journal of Experimental Medicine 57: 419–433 (1933).
Bird, H.A.: Ring, E.F.J.; Daniel, R. and Bacon, P.A.: Comparison of intra-articular methotrexate with intra-articular triamcinolone hexacetonide by thermography. Current Medical Research and Opinion 5: 141–146 (1977).
Campbell, W.G. Jr. Synovial fine structure and permeability after intra-articular nitrogen mustard. Archives of Pathology 85: 162–174 (1968).
Caruso, I.: Distribution of indomethacin in blood and synovial fluid of patients affected with rheumatoid arthritis. Arzneimittel-Forschung 21: 1824–1826 (1971).
Caruso, I.; Moro, E.; Patrono, C.; Sacchetti, G.; Tomassia, V. and Tosolini, G.P.: Plasma and synovial fluid pharmacokinetics and prostaglandin inhibitory effect of indoprofen in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 9: 123–126 (1980).
Chalmers, T.M.; Glass, R.C. and Marchant, B.: Concentrations of flurbiprofen in serum and synovial fluid from patients with active rheumatoid disease. British Journal of Clinical Practice 9(Suppl.): 3–5 (1980).
Chalmers, T.M.; Glass, R.C. and Risdall, P.C.: Concentrations of flurbiprofen in serum and synovial fluid from patients with active rheumatoid disease: Some preliminary observations. Current Medical Research and Opinion 5: 17–20 (1977).
Chisholm, D.; Waterworth, P.; Calvan, J. and Garrod, L.: Concentration of antibacterial agents in interstitial tissue fluid. British Medical Journal 1: 569–573 (1973).
Christensen, S.B.; Reimann, I.; Henriksen, O. and Arnoldi, C.C.: Experimental osteoarthritis in the rabbit. A study of 133Xenon washout rates from the synovial cavity. Acta Orthopedics Scandinavica 53: 167–174 (1982).
Corsi, E. and Townsend, R.J.: Personal communication. Medical Bioavailability Uni, Upjohn (1981).
Costello, P.B. and Green, F.A.: Aspirin survival in human blood modulated by the concentration of erythrocytes. Arthritis and Rheumatism 25: 550–555 (1982).
Costello, P.B.; Green, F.A. and Jung, C.Y.: Free versus bound salicylate concentration in adults and children with chronic inflammatory joint disease. Arthritis and Rheumatism 25: 32–37 (1982).
Cressman, W.A.; Wortham, G.F. and Plostnicks, J.: Absorption and excretion of tolmetin in man. Clinical Pharmacology and Therapeutics 19: 224–233 (1976).
Denko, C.W.; Purser, D.B. and Johnson, R.M.: Amino acid composition of serum albumin in normal individuals and in patients with rheumatoid arthritis. Clinical Chemistry 16: 54–57 (1970).
Deodhar, S.D.; O’Boyle, P.J. and Dick, W.C.: Anion transport from the canine synovial cavity. Nature New Biology 231: 61–63 (1971).
Desiraju, R.K.; Nayak, R.K.; Furst D.E. and Paulus, H.E.: Steady state serum and synovial fluid concentrations of tolmetin and its metabolites in arthritis patients. Personal communication (1982).
Emori, H.W.; Champion, G.D.; Bluestone, R. and Paulus, H.E.: Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid. Annals of the Rheumatic Diseases 32: 433–435 (1973).
Falchuck, K.H.; Goetzl, E.J. and Kulka, J.P.: Respiratory gases of synovial fluids: An approach to synovial tissue circulatory-metabolic imbalance in rheumatoid arthritis. American Journal of Medicine 49: 223–231 (1970).
Farr, M. and Willis, J.V.: Investigation of phenylbutazone in synovial fluid. Journal of International Medical Research 5(Suppl.): 26–29 (1977).
Franke, M.; Manz, G. and Glynn, J.P.: Distribution of benorylate in plasma, synovial fluid and tissue in rheumatoid arthritis. Scandinavian Journal of Rheumatology 13(Suppl.): 13–17 (1976).
Freyberg, R.H.; Black, W.H. and Levey, S.: Metabolism, toxicity and manner of action of gold compounds used in the treatment of arthritis. I. Human plasma and synovial fluid concentrations and urinary excretion of gold during and following treatment with gold sodium thiomalate, gold sodium thiosulfate and colloidal gold sulfide. Journal of Clinical Investigation 20: 401–412 (1941).
Fumagalli, M.; Tamassia, V.; Moro, E.; Caruso, I.; Lavegzari, M. and Sacchetti, G.: Pharmacokinetics of indoprofen in synovial fluid after single intra-articular injection. Personal communication (1981).
Gerber, R.C.; Paulus, H.E.; Bluestone, R. and Lederer, M.: Kinetics of aurothiomalate in serum and synovial fluid. Arthritis and Rheumatism 15: 625–629 (1972).
Ghadially, F.N.: The aurosome. Journal of Rheumatology 6(Suppl.): 45–50 (1979).
Glass, R.C. and Swannell, A.J.: Concentrations of ibuprofen in serum and synovial fluid from patients with arthritis. British Journal of Clinical Practice 6(Suppl.): 20–22 (1980).
Goetzl, E.J.; Falchuk, K.H.; Zeiger, L.D.; Sullivan, A.L.; Hobert, C.L.; Adams, J.B. and Decker, J.L.: A physiological approach to the assessment of disease activity in rheumatoid arthritis. Journal of Clinical Investigation 50: 1167–1180 (1971).
Gottlieb, N.L.; Smith, P.M. and Smith, E.M.: Tissue gold concentration in a rheumatoid arthritic receiving chrysotherapy. Arthritis and Rheumatism 15: 16–22 (1972).
Gottlieb, N.L.; Smith, P.M. and Smith, E.M.: Pharmacokinetics of 195-Au labeled aurothiomalate in blood. Correlation with cause of rheumatoid arthritis, gold toxicity and gold excretion. Arthritis and Rheumatism 17: 171–184 (1974).
Grindel, J.M.; Migdalof, B.H. and Plostnieks, J.: Absorption and excretion of tolmetin in arthritic patients. Clinical Pharmacology and Therapeutics 26: 122–128 (1979).
Gumpel, J.M.; Beer, T.C.; Crowiey, J.C.W. and Farran, H.E.A.: Yttrium−90 in persistent synovitis of the knee — a single centre comparison. The retention and extra-articular spread of four Yttrium−90 radiocolloids. British Journal of Radiology 48: 377–381 (1975).
Gumpel, J.M.; Williams, E.D. and Glass, H.I.: Use of Yttrium−90 in persistent synovitis of the knee. I. Retention in the knee and spread in the body after injection. Annals of the Rheumatic Diseases 32: 223–227 (1973).
Hadler, N.M.: The biology of the extracellular space; in Hasselbacher (Ed.) Clinics in Rheumatic Diseases 7: 71–97 (1981).
Hall, G.H.; Jones, B.J.M.; Head, A.C. and Jones, V.E.: Intra-articular methotrexate. Annals of the Rheumatic Diseases 37: 351–356 (1978).
Hollingsworth, P. and Scott, J.T.: Distribution of intra-articular injections into the knee. Annals of the Rheumatic Diseases 40: 201 (1981).
Howell, S.B.; Chu, B.B.F.; Wung, W.E.; Metha, B.M. and Mendelsohn, J.: Long duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions. Journal of Clinical Investigation 67: 1161–1170 (1981).
Jalava, S.; Saarimaa, M.; Anttila, M. and Sundquist, H.: Naproxen concentrations in serum, synovial fluid and synovium. Scandinavian Journal of Rheumatology 6: 155–157 (1977).
Kohler, G. and Mohing, W.: Zur kinetic von Diclofenac-Na in plasma und synovialflussigkeit. Akta Rheumatologica 5: 151–155 (1980).
Kuhns, J.G.: Lymphatic drainage of joints. Archives of Surgery 27: 345–391 (1933).
Kushner, I. and Somerville, J.A.: Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation. Arthritis and Rheumatism 14: 560–570 (1971).
Laine, V.A.; Penn, R.G.; Patiälä, H. and Sibelius, R.: The passage of benorylate into the synovial fluid and tissue of rheumatoid patients. Scandinavian Journal of Rheumatology 13(Suppl.): 18–20 (1975).
Lawrence, J.S.: Studies with radioactive gold. Annals of the Rheumatic Diseases 20: 341–351 (1961).
Leo, A.; Hansch, C. and Elkins, D.: Partition coefficients and their uses. Chemical Reviews 71: 525–616 (1971).
Levy, G.: Clinical pharmacokinetics of salicylates: A re-assessment. British Journal of Clinical Pharmacology 10: 2855–2905 (1980).
Levy, G. and Koysooko, R.: Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children. Journal of Pediatrics 86: 789–793 (1975).
Ligniêre, G.C.; Colombo, B.; Carrabba, M.; Ferrarri, P. and Gallazzi, A.: DA2370 serum and synovial fluid concentrations in patients with rheumatoid arthritis. Current Medical Research and Opinion 2: 51–56 (1974).
Mäkelä, A.L.; Lempiainen, M. and Yrjänä, T.: Ibuprofen in the treatment of juvenile rheumatoid arthritis: Metabolism and concentrations in synovial fluid. British Journal of Clinical Practice 6(Suppl.): 23–27 (1980).
Mäkelä, A.; Lempiäinen, M. and Ylijoki, H.: Ibuprofen levels in serum and synovial fluid. Scandinavian Journal of Rheumatology 39(Suppl.): 15–17 (1981).
Meyer, H.: Zur theorie der alkoholnarkose. Archiv Experimental Pathologie und Pharmacologie 46: 338–346 (1901).
Mitchell, W.S.; Scott, P.; Kennedy, A.C.; Brooks, P.M.; Templeton, R. and Jeffries, M.G.: Clinico-pharmacological studies on ketoprofen. Current Medical Research and Opinion 3: 423–430 (1975).
Mützel, W.; Tillmann, K. and Gerhards, E.: Time of persistence of fluocortolone hexanoate in the knee-joint after intra-articular injection (author’s translation). Deutsche Medizinische Wochenschrift 104: 293–295 (1979).
Nakamura, H. and Igarashi, M.: Localization of gold in synovial membrane of rheumatoid arthritis treated with sodium aurothiomalate. Studies by electron microscope and electron probe x-ray microanalysis. Annals of the Rheumatic Diseases 36: 209–215 (1977).
Oka, M.: Absorption of hydrocortisone from the joint cavity into the circulation. Annals of the Rheumatic Diseases 15: 327–329 (1956).
Oldendorf, W.H.: Lipid solubility and drug penetration of the blood brain barrier. Proceedings of the Society for Experimental Biology and Medicine 147: 813–816 (1974).
Ott, H. and Meier, J.; The distribution of proquazone and three of its metabolites in serum and synovial fluid. Scandinavian Journal of Rheumatology 21(Suppl.): 12–14 (1978).
Overton, E.: Studen uber narkose. Jern, Fischer (1901).
Peterson, R.E.; Black, R.L. and Burnium, J.J.: Disposition of intra-articularly injected cortisone and hydrocortisone. Arthritis and Rheumatism 2: 433–439 (1959).
Phelps, P.A.; Steele, D. and McCarty, D.J.: Significance of xenon-133 clearance rate from canine and human joints. Arthritis and Rheumatism 15: 360–369 (1972).
Rabinowitz, J.L.; Feldman, E.S.; Weinberger, A. and Schumacher, H.R.: Comparative tissue absorption of oral 14C-aspirin and topical triethanolamine 14C-salicylate in human and canine knee joints. Journal of Clinical Pharmacology 22: 42–48 (1982).
Ramsey, N.W.: Retention of 90yttrium in patients with RA. Annals of the Rheumatic Diseases 32: 38–40 (1973).
Ray, J.E.; Wade, D.N.; Graham, G.G. and Day, R.O.: Pharmacokinetics of carprofen in plasma and synovial fluid. Journal of Clinical Pharmacology 19: 635–643 (1979).
Reuning, R.H.; Sams, R. and Notari, R.: Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin. Journal of Clinical Pharmacology 13: 127–141 (1973).
Rosenthal, R.K.; Bayles, T.B. and Fremont-Smith, K.: Simultaneous salicylate concentrations in synovial fluid and plasma in rheumatoid arthritis. Arthritis and Rheumatism 7: 103–109 (1964).
Sallis, J.G. and Perry, J.: Absorption from the synovial cavity in rabbits and cats. The influence of different environments and drugs. South African Journal of Medical Science 32: 83–95 (1967).
Scott, R.W.; Thoburn, T.W. and Hanzlik, P.J.: The salicylates. IV. Salicylate in the blood and joint fluid of individuals receiving full therapeutic doses of the drug. Journal of Pharmacology and Experimental Therapeutics 9: 217–225 (1917).
Selley, M.L.; Madsen, B.W. and Thomas, J.: Protein binding of tolmetin. Clinical Pharmacology and Therapeutics 24: 694–705 (1978).
Shapiro, W.; Narahara, K. and Taubert, K.: Relationship of plasma digitoxin and digoxin following intravenous digitalization in man. Circulation 42: 1065–1072 (1970).
Sholkoff, S.D.; Eyring, E.J.; Rowland, M. and Riegelman, S.: Plasma and synovial fluid concentrations of aspirin in patients with rheumatoid arthritis. Arthritis and Rheumatism 10: 348–351 (1967).
Simkin, P.A.: Synovial permeability in rheumatoid arthritis. Arthritis and Rheumatism 22: 689–696 (1979).
Simkin, P.A. and Nilson, K.L.: Trans-synovial exchange of large and small molecules, in Hasselbacher (Ed.) Clinics in Rheumatic Diseases 7: 99–129 (1981).
Simkin, P.A. and Pizzorno, J.E.: Transynovial exchange of small molecules in normal human subjects. Journal of Applied Physiology 36: 581–587 (1974).
Soren, A.: Salicylates in blood and joint fluid after ingestion of buffered aspirin. Clinical Orthopaedics 68: 322–328 (1970).
Soren, A.: Transport of salicylates from blood to joint fluid. Archives of Internal Medicine 132: 668–672 (1973).
Soren, A.: Transport time for salicylates from blood to joint fluid — a test of histopathology of the synovial membrane. Zeitschrift für Rheumatologie 34: 213–220 (1975).
Soren, A.: Dissociation of acetylsalicylic acid in blood and joint fluid. Scandinavian Journal of Rheumatology 6: 17–22 (1977).
Thomas, G.M.; Rees, P.; Dippy, J.E. and Maddock, J.: Simultaneous pharmacokinetics of alclofenac in plasma and synovial fluid in patients with rheumatoid arthritis. Current Medical Research and Opinion 3: 264–267 (1975).
Trnavská, J. and Trnavsky, K.: Characterization of salicylate binding to synovial fluid and plasma proteins in patients with rheumatoid arthritis. European Journal of Clinical Pharmacology 18: 403–406 (1980).
Wallis, W.J.; Simkin, P.A.; Nelp, W.B. and Foster, D.M.: In rheumatoid arthritis, reduced effective synovial blood flow is associated with synovial fluid of lower glucose, pH and temperature (abstract). Clinical Research 31: 47A (1983).
Wanwimolruk, S.; Birkett, D.J. and Brooks, P.M.: Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis. Clinical Pharmacokinetics 7: 85–92 (1982).
Whitlam, J.B.; Brown, K.F.; Crooks, M.J. and Room, G.F.: Transynovial distribution of ibuprofen in arthritic patients. Clinical Pharmacology and Therapeutics 29: 487–492 (1981).
Wigginton, S.M.; Chu, B.F.; Weisman, M.H. and Howell, S.B.: Methotrexate pharmacokinetics after intra-articular injection in patients with rheumatoid arthritis. Arthritis and Rheumatism 23: 119–122 (1980).
Wilson, H.; Glyn, J.; Scull, E.; McEwen, C. and Ziff, M.: Rate of disappearance and metabolism of hydrocortisone and cortisone in the synovial cavity in rheumatoid arthritis. Proceedings of the Society for Experimental Biology and Medicine 83: 648–654 (1953).
Wilson, H.; Fairbanks, R.; McEwen, C. and Ziff, M.: Studies on the metabolism of adrenal cortical steroids in the synovial cavity in rheumatoid arthritis. Annals of the New York Academy of Sciences 61: 502–510 (1955).
Winter, J.A.; Sandberg, A.A.; Saroff, J. and Slaunwhite, W.R.: Disposition and metabolism of intra-articular injected 4-14C-cortisol in rheumatoid arthritis. Arthritis and Rheumatism 10: 352–356 (1967).
Author information
Authors and Affiliations
Additional information
† Supported in part by grants T32 AM 07108 and AM 22186 from the National Institutes of Health and by the Arthritis Clinical Research Center grant from the Arthritis Foundation.
Rights and permissions
About this article
Cite this article
Wallis, W.J., Simkin, P.A. Antirheumatic Drug Concentrations in Human Synovial Fluid and Synovial Tissue Observations on Extravascular Pharmacokinetics. Clin Pharmacokinet 8, 496–522 (1983). https://doi.org/10.2165/00003088-198308060-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198308060-00002